Free Submission Public Relations &
Deutsch English


Elmar Burchardt to Speak at Stem Cell Summit (Apr 23-25, 2014 - Cambridge, MA)

Print article Print article
2014-01-27 06:27:34 - Elmar Burchardt, VP of Regenerative Medicine at Pfizer, to Keynote Present at Stem Cell Summit (Apr 23-25, 2014 in Cambridge, MA)

Elmar Burchardt, Vice President of Regenerative Medicine at Pfizer, will give a Keynote Presentation at the Stem Cell Summit 2014 to be held on April 23-25, 2014 in Cambridge, MA.

With over 17 years of experience in the areas of cell therapy, hematology and cardiovascular diseases, Dr. Burchardt has designed and conducted international clinical trials from Phases I through IV, including hematopoietic stem cell transplantation and studies in hematology, immunology, oncology, bone regeneration and in cardiovascular diseases.

In its 11th year, the Stem Cell Summit 2014 includes two parallel conferences including joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and commercialization of stem cells.

Conference A: Stem

Cell Research & Regenerative Medicine:
Advances in Adult & Pluripotent Stem Cells
New Paradigms in Cell Therapy
Tissue Engineering
Cells for Drug Discovery & Diagnostics

Conference B: Stem Cell Commercialization & Partnering:
Novel Technologies in Stem Cell Research
Overcoming Challenges in Clinical Development
Commercialization: Bringing Therapeutics to Market
Panel Discussion: Strategic Partnering

Joint Sessions: (Conference A+B)
Applications of Regulatory guidance in Advancing Cell Therapy
Funding Opportunities

For more information, please visit

Contact Information:

635 W. Foothill Blvd. Monrovia, CA 91016

Contact Person:
Kristen Starkey

Phone: 6262566405
email: email


Rania hafez
Phone: 626-256-6405

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact